Tandem Diabetes Care is a medical device company focused on the design, development and commercialization of technology solutions for people living with diabetes. Co.'s manufacturing, sales and support activities principally focus on its primary pump platform, the t:slim X2 and its complementary product offerings. Co.'s simple-to-use t:slim X2 is based on its proprietary technology platform and is an insulin pump available in the U.S. Co. has commercially provided several automated insulin dosing algorithms on t:slim X2, including its Control-IQ technology, which is a hybrid-closed loop feature, designed to help increase a user's time in their targeted glycemic range. The TNDM stock yearly return is shown above.
The yearly return on the TNDM stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the TNDM annual return calculation with any dividends reinvested as applicable (on ex-dates).
|